Displaying One Session

View
Channel 3 ESMO Colloquium

ESMO Colloquium supported by Astellas Pharma Singapore Pte. Ltd.: Optimising outcomes of patients with advanced prostate and urothelial cancer (ID 90)

Date
21.11.2020
Time
17:35 - 19:05
Location
Channel 3
Chairs
  • Ravindran Kanesvaran (Singapore, Singapore)
  • Karim Fizazi (Villejuif, France)
ESMO Colloquium supported by Astellas Pharma Singapore Pte. Ltd.: Optimising outcomes of patients with advanced prostate and urothelial cancer (ID 90) ESMO Colloquium

Optimal combinations of systemic therapies in treatment-naïve patients with advanced hormone-sensitive prostate cancer: Which ones and for which patients? (ID 1163)

Lecture Time
17:35 - 17:50
Speakers
  • Arnulf Stenzl (Tuebingen, Germany)
Session Name
ESMO Colloquium supported by Astellas Pharma Singapore Pte. Ltd.: Optimising outcomes of patients with advanced prostate and urothelial cancer (ID 90)
Location
Channel 3, Virtual Meeting, Virtual Meeting, Singapore
Date
21.11.2020
Time
17:35 - 19:05
ESMO Colloquium supported by Astellas Pharma Singapore Pte. Ltd.: Optimising outcomes of patients with advanced prostate and urothelial cancer (ID 90) ESMO Colloquium

How do modern first-line combination regimens affect the therapeutic algorithm in later lines of therapy in metastatic prostate cancer? (ID 1164)

Lecture Time
17:50 - 18:05
Speakers
  • Karim Fizazi (Villejuif, France)
Session Name
ESMO Colloquium supported by Astellas Pharma Singapore Pte. Ltd.: Optimising outcomes of patients with advanced prostate and urothelial cancer (ID 90)
Location
Channel 3, Virtual Meeting, Virtual Meeting, Singapore
Date
21.11.2020
Time
17:35 - 19:05
ESMO Colloquium supported by Astellas Pharma Singapore Pte. Ltd.: Optimising outcomes of patients with advanced prostate and urothelial cancer (ID 90) ESMO Colloquium

State of the art therapeutic landscape in non-metastatic castration-resistant prostate cancer (ID 1165)

Lecture Time
18:05 - 18:20
Speakers
  • Wai Kay P. Kwong (Hong Kong, Hong Kong PRC)
Session Name
ESMO Colloquium supported by Astellas Pharma Singapore Pte. Ltd.: Optimising outcomes of patients with advanced prostate and urothelial cancer (ID 90)
Location
Channel 3, Virtual Meeting, Virtual Meeting, Singapore
Date
21.11.2020
Time
17:35 - 19:05
ESMO Colloquium supported by Astellas Pharma Singapore Pte. Ltd.: Optimising outcomes of patients with advanced prostate and urothelial cancer (ID 90) ESMO Colloquium

Emerging systemic therapies in unresectable bladder cancer: Immunotherapy, kinase inhibitors and antibody-drug conjugates (ID 1166)

Lecture Time
18:20 - 18:35
Speakers
  • Matthew Galsky (New York, United States of America)
Session Name
ESMO Colloquium supported by Astellas Pharma Singapore Pte. Ltd.: Optimising outcomes of patients with advanced prostate and urothelial cancer (ID 90)
Location
Channel 3, Virtual Meeting, Virtual Meeting, Singapore
Date
21.11.2020
Time
17:35 - 19:05
ESMO Colloquium supported by Astellas Pharma Singapore Pte. Ltd.: Optimising outcomes of patients with advanced prostate and urothelial cancer (ID 90) ESMO Colloquium

Q&A, live discussion and wrap up (ID 1168)

Lecture Time
18:35 - 19:05
Speakers
  • Ravindran Kanesvaran (Singapore, Singapore)
Session Name
ESMO Colloquium supported by Astellas Pharma Singapore Pte. Ltd.: Optimising outcomes of patients with advanced prostate and urothelial cancer (ID 90)
Location
Channel 3, Virtual Meeting, Virtual Meeting, Singapore
Date
21.11.2020
Time
17:35 - 19:05